Metraipolis › archive › dc_f16f9d016df4

Innovative γ-Oryzanol and KC2 Based Lipid Nanoparticles: OryKL Platform Provides Safe and Efficient In Vivo mRNA Delivery — Europe PMC PMID:41847953

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41847953
DOI
10.1002/smll.202511946
License (as archived)
solo-consultazione
Archived
2026-11-04T07:51:58.812Z
SHA-256 of the archived text
5b30e2361db049c101e4b595bf7835a25491b8815dcfbc388b0cc16f80b05ad3
Stable URL of this page
https://metraipolis.com/documento/dc_f16f9d016df4

How to cite

Innovative γ-Oryzanol and KC2 Based Lipid Nanoparticles: OryKL Platform Provides Safe and Efficient In Vivo mRNA Delivery — Europe PMC PMID:41847953 — Europe PMC (en), https://europepmc.org/article/MED/41847953 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f16f9d016df4 (Metraipolis archive dc_f16f9d016df4, sha256 5b30e2361db049c101e4b595bf7835a25491b8815dcfbc388b0cc16f80b05ad3)
BibTeX
@misc{dcf16f9d016df4,
  title = {Innovative γ-Oryzanol and KC2 Based Lipid Nanoparticles: OryKL Platform Provides Safe and Efficient In Vivo mRNA Delivery — Europe PMC PMID:41847953},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41847953},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f16f9d016df4; sha256 5b30e2361db049c101e4b595bf7835a25491b8815dcfbc388b0cc16f80b05ad3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41847953. Agents can read the archived copy with the MCP tool read_document.